Treatment with relugolix and concomitant therapies for prostate cancer showed similar safety and efficacy to relugolix alone in a recent study. Treatment with relugolix and concomitant therapies for ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified 645 patients with IPF (mean age, 69 years; 76% men) who received nintedanib (Ofev, ...

Please provide your email address to receive an email when new articles are posted on . Concomitant medication burden is associated with antifibrotic medication intolerance among patients with ...

The prognostic significance of concomitant statin use in cancer treatment with immune checkpoint inhibitors (ICIs) remains a subject of ongoing investigation. This study aims to clarify the prognostic ...

To highlight the importance of actively looking for concomitant cCMV as a routine evaluation of patients presenting with cholestasis and receiving a diagnosis of an inherited liver disease, ...